Indeed, it says its technology will allow doctors to access early -
stage lung cancer without incisions, allowing for more accurate diagnosis, as well as more targeted treatment.
A Phase III Randomized Trial of Adjuvant Chemotherapy with or
without Bevacizumab for Patients with Completely Resected
Stage IB (> or = 4 cm)- IIIA Non-Small Cell
Lung Cancer (NSCLC)